EUVIMEDExplore EUVIMED
EUVIMED · CrossrefJournal

Kanzo

ISSN 0451-4203 · Japan Society of Hepatology

Latest articles

  1. Early Complete Response Before the Second Cycle of Atezolizumab plus Bevacizumab After Locoregional Therapy in Advanced Hepatocellular Carcinoma with Multiple Intrahepatic Lesions and Pulmonary Metastases

    Hiroteru Kamimura, Shun Yamazaki, Hiroki Natsui, Saori Endo, Suguru Miida, Hiroki Maruyama, Kaoru Hanano, Kotaro Yoshida, Naoya Fukushima, Ken Morishita, Shunta Yakubo, Masaru Kumagai, Tomoaki Yoshida, Naruhiro Kimura, Hiroyuki Abe, Takeshi Yokoo, Akira Sakamaki, Shuji Terai

    Published: 2026-07-01DOI: 10.2957/kanzo.67.345

Volumes

2026 · 742025 · 962024 · 982023 · 1002022 · 952021 · 1382020 · 1332019 · 812018 · 1102017 · 1132016 · 1102015 · 1082014 · 1222013 · 972012 · 942011 · 972010 · 1012009 · 962008 · 692007 · 812006 · 832005 · 1032004 · 1372003 · 1372002 · 1212001 · 1322000 · 2041999 · 2121998 · 2051997 · 2001996 · 1771995 · 1621994 · 1941993 · 2161992 · 2081991 · 2391990 · 2931989 · 2771988 · 3081987 · 316

Knowledge that fits your work.

From a free start through personal literature research to the complete Research Suite.

View plans →

Are all publisher full texts included?

No. Bibliographic records, abstracts and full texts are different content types. Full-text availability depends on the source, open access and your existing licences. An EUVIMED plan does not replace additional publisher rights.